These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9817522

  • 1. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia.
    Norrby SR, Petermann W, Willcox PA, Vetter N, Salewski E.
    Scand J Infect Dis; 1998; 30(4):397-404. PubMed ID: 9817522
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    File TM, Segreti J, Dunbar L, Player R, Kohler R, Williams RR, Kojak C, Rubin A.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
    [Abstract] [Full Text] [Related]

  • 3. A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia.
    Petermann W, Alegre-Martin J, Odenholt I, Phillips MJ, Willcox PA, Tack K, Trostmann U, Welling L.
    Scand J Infect Dis; 2001 Sep; 33(11):832-7. PubMed ID: 11760164
    [Abstract] [Full Text] [Related]

  • 4. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC, MOTIV (MOxifloxacin Treatment IV) Study Group.
    Clin Infect Dis; 2008 May 15; 46(10):1499-509. PubMed ID: 18419482
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia.
    Frank E, Liu J, Kinasewitz G, Moran GJ, Oross MP, Olson WH, Reichl V, Freitag S, Bahal N, Wiesinger BA, Tennenberg A, Kahn JB.
    Clin Ther; 2002 Aug 15; 24(8):1292-308. PubMed ID: 12240780
    [Abstract] [Full Text] [Related]

  • 6. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H, File TM, Mandell L, Ball P, Pypstra R, Thomas M, 185 Gemifloxacin Study Group.
    Clin Ther; 2002 Nov 15; 24(11):1915-36. PubMed ID: 12501883
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
    Zervos M, Mandell LA, Vrooman PS, Andrews CP, McIvor A, Abdulla RH, de Caprariis PJ, Knirsch CA, Amsden GW, Niederman MS, Lode H.
    Treat Respir Med; 2004 Nov 15; 3(5):329-36. PubMed ID: 15606222
    [Abstract] [Full Text] [Related]

  • 8. [Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization].
    Kalbermatter V, Bagilet D, Diab M, Javkin E.
    Med Clin (Barc); 2000 Nov 04; 115(15):561-3. PubMed ID: 11141388
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    File TM, Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley IA, Thye DA, FOCUS 1 investigators.
    J Antimicrob Chemother; 2011 Apr 04; 66 Suppl 3():iii19-32. PubMed ID: 21482566
    [Abstract] [Full Text] [Related]

  • 13. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    Low DE, File TM, Eckburg PB, Talbot GH, David Friedland H, Lee J, Llorens L, Critchley IA, Thye DA, FOCUS 2 investigators.
    J Antimicrob Chemother; 2011 Apr 04; 66 Suppl 3():iii33-44. PubMed ID: 21482568
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS, Arguedas A, Blumer JL, Sáez-Llorens X, Melkote R, Noel GJ.
    Pediatr Infect Dis J; 2007 Oct 04; 26(10):868-78. PubMed ID: 17901791
    [Abstract] [Full Text] [Related]

  • 15. Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
    Ortiz-Ruiz G, Vetter N, Isaacs R, Carides A, Woods GL, Friedland I.
    J Antimicrob Chemother; 2004 Jun 04; 53 Suppl 2():ii59-66. PubMed ID: 15150184
    [Abstract] [Full Text] [Related]

  • 16. Levofloxacin in the treatment of community acquired pneumonia.
    File TM.
    Can Respir J; 1999 Jun 04; 6 Suppl A():35A-9A. PubMed ID: 10202232
    [Abstract] [Full Text] [Related]

  • 17. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF, Goa KL.
    Drugs; 2003 Jun 04; 63(24):2769-802. PubMed ID: 14664657
    [Abstract] [Full Text] [Related]

  • 18. Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia.
    Erard V, Lamy O, Bochud PY, Bille J, Cometta A, Calandra T.
    Eur J Clin Microbiol Infect Dis; 2004 Feb 04; 23(2):82-8. PubMed ID: 14727149
    [Abstract] [Full Text] [Related]

  • 19. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.
    Curr Med Res Opin; 2008 Mar 04; 24(3):895-906. PubMed ID: 18419876
    [Abstract] [Full Text] [Related]

  • 20. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Ortiz-Ruiz G, Caballero-Lopez J, Friedland IR, Woods GL, Carides A, Protocol 018 Ertapenem Community-Acquired Pneumonia Study Group.
    Clin Infect Dis; 2002 Apr 15; 34(8):1076-83. PubMed ID: 11914996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.